Oxford Cannabinoid Technologies has signed agreements to accelerate the development of a pain management solution using phytocannabinoids.
Oxford Cannabinoid Technologies has signed a worldwide exclusive licence agreement with Canopy Growth Corporation.
The Centers for Disease Control (CDC) and the Food and Drug Administration have issued official health warnings to Americans who are
On this episode of BofC Live, we connect with Dr. Mather Carscallen, the CEO and CTO of Algae-C – a
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
